Overview
Yoshihisa Kobayashi practices in Tokyo, Japan. Kobayashi is rated as an Advanced expert by MediFind in the treatment of Lymphangitis. Their top areas of expertise are EGFR Positive Lung Cancer, Lung Cancer, Lymphangitis, and Non-Small Cell Lung Cancer (NSCLC).
Their clinical research consists of co-authoring 47 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of Lymphangitis.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- EGFR Positive Lung CancerKobayashi isDistinguished. Learn about EGFR Positive Lung Cancer.
- Advanced
- Lung CancerKobayashi isAdvanced. Learn about Lung Cancer.
- LymphangitisKobayashi isAdvanced. Learn about Lymphangitis.
- Experienced
- Lung AdenocarcinomaKobayashi isExperienced. Learn about Lung Adenocarcinoma.
- Lung MetastasesKobayashi isExperienced. Learn about Lung Metastases.
- Non-Small Cell Lung Cancer (NSCLC)Kobayashi isExperienced. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Pleural EffusionKobayashi isExperienced. Learn about Pleural Effusion.